The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Level | Code | Title | |
---|---|---|---|
1 | N | Nervous system | |
2 | N01 | Anesthetics | |
3 | N01A | Anesthetics, general | |
4 | N01AX | Other general anesthetics |
Code | Title | |
---|---|---|
N01AX03 | Ketamine | |
N01AX04 | Propanidid | |
N01AX05 | Alfaxalone | |
N01AX07 | Etomidate | |
N01AX10 | Propofol | |
N01AX11 | Hydroxybutyric acid | |
N01AX13 | Nitrous oxide | |
N01AX14 | Esketamine | |
N01AX15 | Xenon | |
N01AX63 | Nitrous oxide, combinations |
Active Ingredient | Description | |
---|---|---|
Esketamine |
Esketamine, the S-enantiomer of racemic ketamine, is a non-selective, non-competitive antagonist of the N-methyl-D-aspartate (NMDA) receptor, an ionotropic glutamate receptor. Through NMDA receptor antagonism, esketamine produces a transient increase in glutamate release. Restoration of dopaminergic neurotransmission in brain regions involved in the reward and motivation, and decreased stimulation of brain regions involved in anhedonia, may contribute to the rapid response. |
|
Etomidate |
Etomidate is an imidazole derivative with short-acting sedative, hypnotic, and general anesthetic properties. Etomidate appears to have gamma-aminobutyric acid (GABA) like effects, mediated through GABA-A receptor. The action enhances the inhibitory effect of GABA on the central nervous system by causing chloride channel opening events which leads to membrane hyperpolarization. |
|
Ketamine |
Ketamine is a rapidly acting general anaesthetic for intravenous or intramuscular use with a distinct pharmacological action. Ketamine hydrochloride produces dissociative anaesthesia characterised by catalepsy, amnesia, and marked analgesia which may persist into the recovery period. |
|
Nitrous oxide (N2O) |
Nitrous oxide is a potent analgesic and a weak anaesthetic. Induction with nitrous oxide is relatively rapid, but a concentration of about 70% is needed to produce unconsciousness. |
|
Propofol |
Propofol (2, 6-diisopropylphenol) is a short-acting general anaesthetic agent with a rapid onset of action of approximately 30 seconds. |
|
Sodium oxybate |
|
Title | Information Source | Document Type | |
---|---|---|---|
DIPRIVAN Emulsion for injection or infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
HYPNOMIDATE Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
KETALAR Solution for injection or infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
PROPOVEN Emulsion for injection/infusion | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
PROVIVE Emulsion for injection | Medicines and Medical Devices Safety Authority (NZ) | MPI, EU: SmPC |